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Abstract  
Objectives 
Interstitial cystitis (IC) is considered to manifest Hunner’s lesion or glomerulation in the 
bladder based on NIDDK criteria, but the pathology remains elusive. While Hunner’s 
lesion display an inflammatory gene signature, intrinsic abnormalities of the urothelium 
per se are largely unknown. Tissue specific master transcription factors (TFs) play 
pivotal roles in human development and disease, and we sought to characterize IC 
pathology based on the expression profile of urothelial master TFs. 
Methods 
To identify candidate urothelial master TFs, we used bladder carcinoma cell lines which 
are derived from the urothelial stem cells but display two contrasting characteristics: 
epithelial or mesenchymal. Gene expression was measured with quantitative RT-PCR. 
From the initial screening of 170 TFs (human homologs of Drosophila segmentation 
genes and known master TFs from a database), 28 TFs were selected. Subsequently we 
purified mRNA from bladder biopsies of IC patients and measured gene expression 
levels of known urothelial marker genes and candidate master TFs. Multivariate 
expression data were analyzed with SPSS software. 
Results 
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Factor analysis decomposed the expression profile into four axes: Principal Axis (PA) 1 
included retinoic acid (RA) receptors and 17 candidate master TFs. PA2 included KRT5 
and five candidates. PA3 included transcription factor TP63 and two candidates. PA4 
included SHH and two candidates. Principal component (PC) analysis segregated 
biopsies from Hunner’s lesion in the PC1(RA)/PC2(SOX13)/PC3(TP63) space. 
Conclusions 
We developed a method to characterize IC biopsies based on the urothelial master TF 
signature and Hunner’s lesion might be defined as ‘decreased progenitors and higher 
regeneration’. 
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Introduction 
Interstitial cystitis (IC) is diagnosed by three requisites: symptoms (hypersensitivity, 
urinary frequency, bladder discomfort and pain), cystoscopic findings (Hunner’s lesion 
as ‘ulcerative’ or bladder glomerulation after hydrodistension as ‘non-ulcerative’), and 
exclusion of confusable diseases. Hunner’s lesion is observed as a circumscript, reddish 
mucosal spot with small vessels radiating towards a central scar, with a fibrin deposit or 
coagulum attached to this area. This site ruptures with increasing bladder distension, 
with petechial oozing of bladder from the lesion and the mucosal margins in a waterfall 
manner.
1,2
 Inflammatory collapse of umbrella cells is a major burden but the pathology 
of IC remains elusive.
3-6
 Currently there is no curative or satisfactory treatment for IC. 
Therefore, elucidation of IC pathology is critical to improve diagnosis and radical 
treatment.
1,7
 Recently, genome scientists have been keen to characterize master 
transcription factors (TFs) for human development and disease.
8-10
 Master TFs control a 
battery of target genes critical for cellular identities and are themselves under 
feedforward regulation by their own super enhancers.
8-10
 Thus, identification of master 
TFs represents a novel molecular approach to understand human development and 
diseases. In this study, we sought to characterize IC pathology based on gene expression 
profiles of urothelial master TFs. First, we screened candidate master TFs to understand 
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the crucial transcription cascades in patients’ urothelium. Second, we investigated 
expression profiles of known urothelial marker genes and candidate master TFs in 
bladder biopsies of IC patients. Multivariate analysis decomposed four principal factors 
that reflect urothelial development and regeneration. We found that biopsies from 
Hunner’s lesion display a characteristic ‘decreased progenitors and higher retinoic acid 
signaling’. 
 
Materials and Methods 
Patients and biospecimens 
This study was approved by the Institutional Review Board of our university hospital 
(ID: 27023), on the basis of the ethical guidelines. Patients who were diagnosed as 
having interstitial cystitis (IC) at our university hospital agreed to donate their bladder 
biopsies for research purposes. 
 
Punch biopsy protocol 
The sampling (punch biopsy) was performed endoscopically from the Hunner’s lesion, 
trigonal region, and other parts of the bladder before the bladder hydrodistension. The 
size of specimens is around 1-2 mm. If the patient did not have a Hunner’s lesion, the 
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urothelium with or without glomerulation during the bladder hydrodistension was 
sampled. However, punch biopsy from the bladder dome was avoided due to the high 
risk of bladder rupture. 
 
Cell culture 
We used bladder carcinoma cell lines which did or did not retain urothelial 
characteristics as initial screening material. BOY-12E (RCB2627), JMSU1 (RCB2227), 
T24 (RCB0431), and 5637 (RCB1191) cell lines were purchased from RIKEN 
Bio-resource Center (Tsukuba, Japan). HuB6 (named after Human Bladder) and HuB15 
transitional carcinoma cell lines were established in our university hospital and 
described elsewhere.
11
 We classified these cell lines into either epithelial (E) or 
mesenchymal (M) type, according to E-cadherin (a pan-epithelial marker) synthesis 
(Supplementary Figure S1A). 5637, HuB6 and HuB15 synthesized abundant E-cadherin 
and were grouped into E-type, while BOY-12E, JMSU1 and T24 were grouped into 
M-type (Supplementary Figure S1A). E-type cell lines concomitantly synthesized 
transcription factor TP63, a master regulator of stratified epithelium (Supplementary 
Figure S1A).
12,13
 In general, bladder carcinoma is a tumor derived from urothelial stem 
cells
14
 and several TFs in bladder diseases had been investigated in previous study, such 
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as c-Jun and E2F-1.
15,16
 Importantly, bladder carcinoma frequently display 
mesenchymal phenotype through epithelial to mesenchymal transition (EMT). For 
example, a well-established cell line T24 is known for mesenchymal characteristics 
through EMT.
17
 We hypothesized that the two contrasting behaviors (i.e. E- or M-type) 
could be exploited for screening of candidate urothelial master TFs (see below). The 
four purchased cell lines were cultured under supplier-recommended conditions (for 
details, visit the website http://cell.brc.riken.jp/en/). HuB6 and HuB15 were cultured 
using Dulbecco’s Modified Eagle Medium (Wako, Osaka, Japan) supplemented with 
5% Fetal Bovine Serum (Gibco, Waltham, MA, USA). 
 
Protein extraction and immunoblotting 
Bladder cancer cell lines were fixed with 10% trichloroacetic acid (Wako) and 
whole-cell proteins were dissolved with solubilizing reagent (7 M urea, 2 M thiourea, 
2% Triton X-100, Wako). The entangled genomic DNA was sheared by sonication for 
20 min. The protein concentration was measured using Bradford Protein Assay 
(Bio-Rad, Hercules, CA, USA). Procedures for immunoblotting have been described 
elsewhere.
18
 Primary antibodies used in this study were as follows: E-cadherin antibody 
(#610181) was purchased from BD Transduction Laboratories (Franklin Lakes, NJ, 
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USA). TP63 (#13109), SHH (#2207) and GAPDH (#5174) were from Cell Signaling 
Technologies (Danvers, MA, USA). Representative data are shown in Supplementary 
Figure S1A; experiments were repeated at least twice at different passage points. 
 
Strategy for master transcription factor screening 
The strategy to identify candidate urothelial master transcription factors (TFs) is as 
follows: Master transcription factors are known to have several characteristics 
including: 1) controlling a battery of target genes critical for lineage determination and 
cellular identities, 2) controlling its own gene expression through auto-feedback super 
enhancers, and as a result, 3) maintaining exceptionally high expression levels of their 
own coding genes.
8
 We exploited the third characteristic in our screening criteria 
because of its accessibility: When the mRNA expression level of its coding gene was 
higher in E-type than in M-type cell lines, the TF was defined as a candidate 
(Supplementary Figure S1B). Retinoic acid is a known chemical to induce urothelial 
cell differentiation
19
 and we added all-trans-retinoic acid (ATRA, Wako) treated E-type 
cells to our screening materials. We used different concentrations and durations of 
ATRA because each cell line has different IC50 against ATRA (data not shown). The 
condition of ATRA treatment was as follows: 5637 (20M, four days), HuB6 (5M, five 
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days) and HuB15 (2.5M, six days). We investigated three groups of TFs for the 
screening (Supplementary Figure S1B). The first group (85 genes) belong to 
evolutionary conserved homologues of Drosophila segmentation genes (Caudal, Bicoid, 
Hunchback, Krüppel, Tailless, Even skipped, Hairy, Odd skipped, Paired, Runt, 
Fushitarazu, Sloppy paired, Odd paired and Engrailed). The second group (33 genes) 
belong to master TFs identified from bladder tissue (UCSD_Bladder).
9
 The third group 
(52 genes) belong to master TFs from biopsies of colon crypts or cultured mammary 
epithelial cells (HMEC).
9
 We prioritize the 170 genes because know master TFs are 
developmental regulators evolutionally conserved. From the initial screening of 170 
candidate transcription factors (TFs), 28 TFs were selected based on the following 
criteria: mRNA expression of each coding gene was higher in the epithelial (E) type 
than in the mesenchymal (M) type of bladder carcinoma cell lines (Supplementary 
Figures S1 and S2). TP63 and FOXA1 served as positive controls (Supplementary 
Figure S2). 
 
Quantitative reverse transcription polymerase chain reaction 
Total RNA was purified using RNAiso Plus (Takara, Osaka, Japan). Reverse 
transcription was performed using PrimeScript
TM
 with gDNA Eraser (Takara). 
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Quantification of the copy number of each mRNA was performed using 
QuantStudio3
TM
 Real-Time PCR System (Applied Biosystems, Waltham, MA, USA) 
and the Taqman® method. Data were calculated using the delta-cycle of threshold 
(ΔCT) method. We used the ΔCT parameter for statistical analysis because mRNA 
expression follows a log-normal distribution, whereas ΔCT follows normal distribution. 
Each gene expression is represented as log scale in Table S3 and Table S4, where CT 
value was normalized by either 18S rRNA or CDH1 (E-cadherin). A gene-specific 
fluorescent probe was designed using a web-based program 
(https://qpcr.probefinder.com/organism.jsp). TableS1 shows the primer sequences and 
corresponding fluorescent probes. Gene specific Taqman® probes were purchased from 
Life Technologies, (Waltham, MA, USA, for Cat#, see TableS2). For PCR, 
Thunderbird® Probe qPCR mix (Toyobo, Osaka, Japan) was used and the PCR 
conditions consisted of 40 cycles of two steps (95°C for 15 s and 60°C for 50 s).  
 
Statistical analysis  
Comparison between the two groups (M type cells versus E type cells) and statistical 
differences in mean values (ΔCT) were determined by one-tailed t test (p-value < 0.1) 
using Excel software (Microsoft, Redmond, WA, USA). Statistical differences between 
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the two groups (IC specimens with Hunner’s lesion vs without Hunner’s lesion) were 
determined by two-tailed t test (p-value < 0.05) using Excel. Multivariate analyses for 
IC specimens were performed using SPSS software (IBM, Armonk, NY, USA). We used 
‘principal axis factoring’ as an extraction method and ‘promax with Kaiser 
normalization’ as a rotation method (Supplementary DataS1). Initial extraction 
decreased the dimension down to six but we found that the fifth and sixth axes were less 
relevant due to smaller eigenvalues (Supplementary DataS1) and lower correlation with 
other factors. On the other hand, we performed ‘principal component analysis’ with an 
extraction method ‘promax with Kaiser normalization’. E-type cell lines were added to 
the analysis to estimate the distance between urothelial dysplasia and IC specimens. 27 
variables were chosen to segregate specimens between Hunner’s lesion and ‘apparently 
normal’ (Supplementary DataS2). 
 
Results 
mRNA expression of the 28 candidate TFs as well as known urothelial marker genes 
were measured in IC specimens sampled endoscopically (For all the Log2 expression 
data, see Supplementary TableS3 and TableS4). IC biopsies included various clinical 
status, including ulcerative type biopsies (Hunner’s lesion or ‘apparently normal’ 
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urothelium counterpart from the same patient) and non-ulcerative type biopsies 
(urothelium with or without glomerulation during hydrodistension) (Supplementary 
TableS3 and TableS4). Initially, we noted that E-cadherin expression (encoded by 
CDH1 gene) had a huge variation among different IC specimens (Figure 1A, Log2 
expression range: from 5.29 to 14.96, 815-fold expression difference). Endoscopic 
handling could have resulted in significant variation of epithelial/stromal ratio and we 
presumed that the contaminated stroma (i.e. submucosal tissue and inflammatory cells) 
significantly affected data interpretation. Therefore, we changed the internal control of 
RT-PCR from 18s ribosomal RNA to CDH1 (Figure 1A), thereby exclusively focusing 
on urothelial status. UPK1A expression (uroplakin 1A, a known marker of urothelial 
cells) was lower in IC biopsies from Hunner’s lesion (ulcer positive) compared to 
urothelium from both ulcerative and non-ulcerative patients (collectively defined as 
ulcer negative) (Figure 1B). Moreover, expression of other urothelial marker genes, 
TP63 (Figure 2A), SHH (Figure 2B), or FOXA1 (data not shown, p=0.035) was lower in 
Hunner’s lesion. Conversely, retinoic acid receptor RARA expression was higher in ulcer 
positive compared to ulcer negative urothelium (Figure 2C). Among 28 candidate TFs, 
expression of EVX1 (Figure 3A), OVOL1 (Figure 3A), EHF (Figure 3A), ELF3 (data 
not shown, p=0.046), or GRHL2 (data not shown, p=0.033) was lower in Hunner’s 
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lesion. Conversely, expression of vitamin D receptor VDR (Figure 3B), ELF4 (Figure 
3B), IRF1 (Figure 3B), ETS2 (data not shown, p=0.026), NR4A2 (data not shown, 
p=0.012), or ZBTB7B (data not shown, p=0.019) was higher in ulcer positive compared 
to ulcer negative urothelium. In order to grasp the entire profile, Pearson correlations 
among expression levels of known urothelial markers or candidate TFs are described in 
Supplementary TableS5. We noted that several factors are associated with each other 
and the multivariate expression data could be decomposed to fewer number of 
dimensions. Factor analysis reduced the expression complexity of known urothelial 
markers and the candidate TFs and we chose four axes for convenience of classification 
(Figure 4 and Supplementary DataS1). From the known markers, retinoic acid receptors 
RARA and RXRA were classified into the first axis (Figure 4A, Principal Axis: PA1), and 
the second axis (PA2) was related to the urothelial basal cell marker, KRT5 (Figure 4A). 
Other known markers, KRT7, UPK1B, and UPK3A were classified into PA2 but these 
three were inversely correlated with KRT5 (Figure 4B). The third axis (PA3) included 
four markers, TP63, KRT20, UPK1A, and UPK3B (Figure 4A), which are closely 
associated with each other (Figure 4B). The fourth axis (PA4) included SHH and 
FOXA2 (Figure 4A). Most candidate TFs were classified according to these criteria but 
some were under-detected (KLF3, KLF15, NR5A2 and FOS) in IC biopsies, and EHF 
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and CEBPG were not classified into the four PAs, due to poor correlation with other 
factors (Figure 4A). Finally, we sought to characterize IC biopsies according to these 
multivariate expression profiles (Figure 5). We added the expression dataset of E-type 
cell lines (initial screening materials) and performed a principal component (PC) 
analysis (Supplementary DataS2). We drew a scatter plot as shown in Figure 5 
according to three principal components. Although there was no remarkable segregation 
between ulcer statuses (black circles: Hunner’s lesion, white circles: ‘apparently normal’ 
urothelium counterparts from ulcerative type patients and urothelium from 
non-ulcerative type patients), biopsies from Hunner’s lesion (black) tended to be located 
in particular PC areas (Figure 5, see discussion). 
 
Discussion 
According to NIDDK criteria, IC patients have either Hunner’s lesion (ulcerative type) 
or glomerulation after hydrodistension (non-ulcerative type) but the boundary between 
them is sometimes obscure.
1
 Importantly, the visible ulcer status does not necessarily 
reflect pain severity and relapse rate.
20
 In contrast, ‘apparently normal’ urothelial 
counterpart of ulcerative IC patients could be ‘pre-malignant’, making the prognostic 
prediction even more difficult. Therefore, it is critical to define the molecular pathology 
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of intractable disease. 
Several groups have reported comprehensive gene expression analyses for IC specimens 
using microarray.
21-23
 Overall, Hunner’s lesion display an inflammatory signature but 
the intrinsic abnormalities in urothelial homeostasis remain unclear. Erickson et al. 
revealed that patient-derived urothelial cells display normal differentiation capacity in 
vitro.
24
 Nevertheless, inflammatory cells and urothelium mutually interact and the 
intrinsic alteration of urothelium in situ remains a pertinent question. In this study, we 
purified mRNA from bladder biopsies sampled endoscopically from IC patients and 
measured known urothelial marker gene expression levels and newly identified 
candidate urothelial master TFs. However, our attempt was hindered by the huge 
variability in CDH1 (E-cadherin) expression (Figure 1A). Practically, it is difficult to 
keep the ratio of epithelial to mesenchymal tissues in the same range during the biopsy 
procedure (see Methods). Mesenchymal tissue including inflammatory cells could 
contribute to ‘mesenchymal noise’ against authentic ‘urothelial signal’. To troubleshoot 
this problem, we switched the normalization gene (internal control) from 18S rRNA to 
CDH1 (Figure 1A). Although the validity of this normalization should be scrutinized, 
more genes displayed altered expression in Hunner’s lesion under E-cadherin 
normalization (Figures 1-3), suggesting that the improved detection could be a 
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consequence of the modified methodology. Moreover, the multivariate data were 
well-correlated with each other (Supplementary TableS3), which prompted further 
analysis. 
Bladder urothelium is organized into three layers, basal, intermediate and superficial 
layers.
19,25
 The superficial layer is covered by umbrella cells, which are terminally 
differentiated cells specialized for mechanical extension (also termed as transition 
epithelium). During tissue injury and regeneration, urothelial progenitor cells inside the 
intermediate layer actively proliferate and replenish the umbrella cells.
19
 We 
decomposed multivariate expression data into four principal axes (PAs) and found that 
the four PAs reflect the known urothelial biology (Figure 4). PA1 included retinoic acid 
receptor RARA and RXRA. Retinoic acid (RA) is a critical signal for urothelial 
development and regeneration.
19
 Mice treated with cyclophosphamide (CPP) display 
rapid peel-off of urothelium, which regenerate after the damage. RA signal is activated 
during such experimental conditions.
19
 RARA expression was higher in Hunner’s lesion 
(Figure 2C), indicating that the urothelium could be undergoing regeneration. PA2 
included KRT5, KRT7, UPK1B, and UPK3A but KRT5 displayed an inverse correlation 
with the other three (Supplementary DataS1). KRT5 is a marker of the urothelial basal 
layer, while KRT7, UPK1B, and UPK3A are markers for the intermediate or superficial 
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layers.
19,25
 We interpreted that PA2 reflects the layer localization inside the 
urothelium.
25
 PA3 included TP63, KRT20, UPK1A, and UPK3B, whereas PA4 included 
SHH and FOXA2 (Supplementary DataS1). TP63, SHH, and FOXA2 are endodermal 
markers and critical regulators for urothelial development.
25
 TP63 is a master TF in 
stratified epithelium
12
 and is localized at the basal and intermediate layers of the 
urothelium.
19,25
 Lineage tracing analysis revealed that TP63 starts its expression in the 
urothelial stem cells.
26
 In contrast, SHH (Sonic Hedgehog) is an evolutionally 
conserved developmental regulator. Developing urothelium and bladder stroma interact 
each other via SHH and WNT signals.
27
 Shh-expressing cells play an important role in 
urothelial progenitors during regeneration in CPP-treated mice.
19,27
  
We subsequently chose the 27 gene expression profile to segregate the Hunner’s lesion 
from ulcer negative specimens in principal component analysis (Figure5). We noted that 
the specimens from Hunner’s lesion tended to be plotted in PC1(RA)high, 
PC2(SOX13)
high
 and PC3(TP63)
low
 (Figure5).  Based on the interpretation of PA1 
(RA) and PA3 (TP63) described above, the pathology of Hunner’s lesion could be 
represented as having ‘augmented regeneration’ and ‘decreased progenitors’. Urothelial 
regeneration should be within the physiological range if the progenitor cell 
replenishment and RA-induced differentiation are coupled with each other. In terms of 
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urothelial biology, Hunner’s lesion could be explained as ‘a disrupted homeostasis due 
to overloaded regeneration’. In future, we would like to obtain further evidence to 
strengthen our hypothesis. 
Finally, we did not use the urothelial biopsies from healthy volunteers. To date, 
non-tumor counterpart tissue from bladder carcinoma patients have been used for 
‘normal urothelial control’ but we used E-type cancer cell lines for the initial screening. 
Such cell lines retain physiological urothelial characters (see methods) and gene 
expression profile is close to IC specimens to some extent (Figure5C). In the future, we 
would like to overcome such technical issue by using cultured urothelial cells 
differentiated from iPS cells. 
In conclusion, candidate urothelial master TFs could serve as novel diagnostic markers 
and potentially explain the molecular pathology of IC. 
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Figure legends 
 
Figure 1 
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mRNA expression in interstitial cystitis (IC) biopsies. A. There is a huge variation in 
E-cadherin gene expression (CDH1) in IC specimens (Log2 expression range: from 5.29 
to 14.96, 815-fold expression difference). To minimize the variance in epithelial/stromal 
ratio, we switched the internal control gene from 18S rRNA to CDH1 (a gene encoding 
E-cadherin) for normalization of other genes of interest. B. mRNA expression of 
UPK1A gene (a known urothelial marker) was lower in Hunner’s lesion (ulcer positive) 
compared to the urothelium from both ulcerative (‘apparently normal’ counterpart) and 
non-ulcerative IC patients (collectively defined as ulcer negative). 
 
 
Figure 2 
mRNA expression of known urothelial marker genes in IC biopsies. A and B. mRNA 
expression of TP63 and SHH genes was lower in ulcer positive compared to ulcer 
negative IC biopsies. C. mRNA expression of RARA gene was higher in ulcer positive 
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compared to ulcer negative IC biopsies. 
 
 
 
Figure 3 
mRNA expression of candidate urothelial master TFs in IC biopsies. A. mRNA 
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expression of EVX1, OVOL1, and EHF genes was lower in ulcer positive compared to 
ulcer negative IC biopsies. B. mRNA expression of VDR, ELF4, and IRF1 genes was 
higher in ulcer positive compared to ulcer negative IC biopsies. 
 
Figure 4 
Candidate master TFs were classified based on expression profile in IC biopsies. A. 
Factor analysis classified candidate TFs into four categories (Principal Axes 1-4), with 
EHF and CEBPG as ungrouped exceptions. B. Three-dimensional factor plot in rotated 
factor space. Each factor represents a ‘Principal Axis’ shown in left.  
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Figure 5 
Expression profile of each IC biopsy was represented in a scatter plot in the Principal 
Components’ plane. A. PC1 (RARA as a representative gene) and PC2 (SOX13 as a 
representative gene). B. PC2 and PC3 (TP63 as a representative gene). C. PC3 and PC1 
Filled circles: biopsies from Hunner’s lesion, open circles: ‘apparently normal’ 
counterpart of Hunner’s lesion from ulcerative patients and urothelium from 
non-ulcerative patients. Filled squares: E-type cell lines (HuB6, HuB15 and 5637) PC: 
Principal Component. 
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